RSS Feeds
Search

Companies

Companies

Displaying 1..10 of 34 - per page Next page
Order by
Profiled on pharmalicensing.com Inven2 AS
Inven2 AS identifies, protects and commercialises inventions and discoveries of the University of Oslo, Oslo University Hospital and other health enterprises in the south-east of Norway. More
Profiled on pharmalicensing.com CrystecPharma
CrystecPharma applies the latest supercritical fluid (SCF) technologies to improve the design and performance of medicines More
Decision Resources Inc.
The worldwide leader in market research publications, advisory services and consulting More
BiotechEast Co., Ltd. (Technology Partner)
BiotechEast is a one-stop, full-service marketing consultancy for those looking to take advantage of the dynamic opportunities in Taiwan's burgeoning life science industry. More
LG Life Sciences
Pharmaceuticals Division, Agrochemicals Division, Animal Health Division More
RAFARM
Development & Marketing of Pharmaceuticals for Human Use More
Biomedica Foscama
Biomedica Foscama is committed in development, production and marketing of prescription pharmaceuticals. The main focus is on cardiovascular, CNS, GI/metabolism and hospital products. More
AstraZeneca
Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority More
PPD
A leading global provider of discovery and development services and products More
Consilient Health Ltd.
We are a young and dynamic marketing and distribution company for quality generic pharmaceuticals in Europe. More
Displaying 1..10 of 34 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Nov 2010 - 5 pages - $500
Acute Coronary Syndromes Therapy Area Pipeline Report
Nov 2010 - 329 pages - $1,495
Acute Coronary Syndromes - Pipeline Review, Q1 2011
Feb 2011 - 62 pages - $500
Epidemiology: Acute Coronary Syndrome - Now affecting primarily the oldest populations
Jul 2011 - 46 pages - $3,800
Innovations in Cardiovascular Disease Management
May 2007 - 183 pages - $2,875
Acute Coronary Syndrome - Pipeline Review, H2 2011
Sep 2011 - 106 pages - $500
Acute Coronary Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 49 pages - $2,000
The Future of Cardiovascular Diagnostics: Impact of technological advances on growth opportunities and future market outlook
Mar 2010 - 180 pages - $3,835
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
The Medicines Company: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile
Jun 2008 - 49 pages - $495
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us